...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The thing is, Zenith CC does publically disclose financial and other information on SEDAR if that is the only issue with regards to Rule 15c2-11

https://www.gibsondunn.com/wp-content/uploads/2022/11/recent-sec-interpretation-of-exchange-act-rule-15c2-11-may-pressure-private-issuers-of-fixed-income-securities-to-publicly-disclose-financial-information.pdf

 

Koo 

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply